Corrigendum: Landscape and predictions of inflammatory bowel disease in China: China will enter the Compounding Prevalence stage around 2030

• Bule Shao,
• Wenjing Yang,
• Qian Cao

Affiliations

Bule Shao

Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China

Wenjing Yang

Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, Hangzhou, China

Qian Cao

Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China